Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -0.035\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCOc1ncccc1C(=O)NCc1ccc(C)cc1
b: Cc1cc(C)nc(SCC(=O)c2cc3ccccc3oc2=O)n1
c: CCn1nc(NC(=O)COC)c2cc3cc(C)ccc3nc21
Answer: b. Cc1cc(C)nc(SCC(=O)c2cc3ccccc3oc2=O)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)nc(SCC(=O)c2cc3ccccc3oc2=O)n1
Cc1cc(C)nc(SCC(=O)c2cc3ccccc3oc2=O)n1
3-[2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetyl]chromen-2-one